Thoracent, Inc.

Thoracent, Inc. is a medical device manufacturer based in Huntington, New York, specializing in pulmonary, thoracic, and gastrointestinal interventional products. The company develops and distributes innovative non-vascular stents manufactured from nitinol woven designs, specifically engineered to open blocked airway passages and GI tracts in patients with malignant lesions. Thoracent's core offering includes the BONASTENT Tracheobronchial Stent—featuring fully covered nitinol construction with an ultra-slim delivery system and recapture capability up to 70% deployment—as well as the BONASTENT Esophageal Stent and Y-Shaped Tracheal Stent (distributed exclusively in the U.S.). The company also supplies complementary procedural instruments including EBUS needles and biopsy forceps for pulmonary interventions. Founded in 2017, Thoracent serves thoracic surgeons, interventional pulmonologists, and gastroenterologists across the U.S. healthcare system, with a mission centered on improving quality of life for patients with terminal airway and GI obstruction.